RVL Pharmaceuticals plc Total Assets
RVL Pharmaceuticals plc had Total Assets of $85.40 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2023-08-14
- 2023-06-30: Assets $85.40M.
- 2023-03-31: Assets $111.11M.
- 2022-12-31: Assets $128.51M.
- 2022-09-30: Assets $155.35M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2023-06-30 | $85.40M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $111.11M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $128.51M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $155.35M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $124.83M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $144.31M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $144.67M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $109.55M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $335.01M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $355.17M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $370.95M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $427.25M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $462.70M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $475.13M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $463.25M 8-K · filed 2021-09-08 | |
| 2019-09-30 | $494.17M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $643.78M 10-Q · filed 2020-08-11 | $643.84M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $775.88M 10-Q · filed 2020-05-12 | $776.15M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $795.62M 10-K · filed 2020-03-19 | $795.64M 10-K · filed 2019-03-28 |
| 2018-09-30 | $894.92M 10-Q · filed 2019-11-14 | $855.47M 10-Q · filed 2018-11-08 |
| 2017-12-31 | $919.51M 8-K · filed 2019-12-20 | $885.70M 10-Q · filed 2018-11-08 |